Case-control Study of Sleep Disorders in Children With Cystic Fibrosis
Sleep Disorders in Patients Aged From 6 to 17 With Cystic Fibrosis: a Single-center Case-control Study at Strasbourg University Hospital
1 other identifier
observational
150
1 country
1
Brief Summary
Our primary purpose is to compare the prevalence of sleep disorders in children aged 6 to 17 with cystic fibrosis versus controls with a Sleep disorder screening score, the SDSC. Our hypothesis is that patients aged 6 to 17 with cystic fibrosis have a higher prevalence of sleep disturbances than the general population of the same age group. Our secondary hypothesis is that these sleep disorders are mixed and that there are non-respiratory causes, sometimes modifiable by simple non-medical treatment and that's why our secondary purpose is to identify the responsible factors, in particular non-respiratory factors in the 2 groups and to compare them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2021
CompletedFirst Posted
Study publicly available on registry
April 19, 2021
CompletedStudy Start
First participant enrolled
May 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedFebruary 17, 2023
February 1, 2023
3 months
April 13, 2021
February 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Questionnaire SDSC
The specific measure for our first purpose is a validated questionnaire called SDSC for "Sleep Disturbance Scale for Children"
15 minutes
Secondary Outcomes (1)
Questionnaire SDSC
15 minutes
Study Arms (2)
Cystic fibrosis, children from 6 to 17.
This group is made up of children with cystic fibrosis followed at the Strasbourg pediatrics CRCM, aged from 6 to 17 years old, not hospitalized at the time of inclusion, without any other criterion prejudging the seriousness of the pathology.
Control group, children from 6 to 17.
This group is the control group. It is made up of children consulting in pediatric surgical emergencies, aged 6 to 17 years. Surgical emergencies were chosen because it is a point of consultation, rather accidental, where sleep has often not been impacted in the previous months and where the frequency of chronic pathology is not higher than the general population. An other criteria is that these children are accompanied by at least one of their parents and that they can read and understand French well.
Interventions
Questionnaire submitted to the parents of children with cystic fibrosis aged 6 to 17 years and to controls in order to assess and compare the prevalence of sleep disorders and their main non-respiratory causes
Eligibility Criteria
Children from 6 to 17 years with cystic fibrosis for the case group and children with an emergency surgical consultation for the control group
You may qualify if:
- Cystic fibrosis followed at the pediatric (Centre de Ressources et de Compétences de la Mucoviscidose) in Strasbourg
- Aged from 6 to 17 years old
- Non hospitalized
- Able to read and understand French language
- Accompanied by at least one of his parents
- Emergency surgical consultation
- Aged from 6 to 17 years old
- Non hospitalized
- Able to read and understand French langage
- Accompanied by at least one of his parents
You may not qualify if:
- Children under 6 years old
- Children over 17 years old
- Children and parents who don't understand or can't read French language
- Hospitalized children
- Children unaccompanied by their parents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpitaux Universitaire de Strasbourg
Strasbourg, 67091, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2021
First Posted
April 19, 2021
Study Start
May 20, 2021
Primary Completion
August 9, 2021
Study Completion
December 20, 2021
Last Updated
February 17, 2023
Record last verified: 2023-02